Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enric Monreal

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Parkinsonism & Related Disorders|October 18, 2019
Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive studyAraceli Alonso-Canovas, José Ignacio Tembl Ferrairó, Irene Martínez-Torres, et al.
Journal of Personalized Medicine|February 25, 2025
Attitudes of Neurologists Toward Serum Neurofilament Light-Chain Testing in the Management of Relapsing-Remitting Multiple Sclerosis with Cognitive ImpairmentJosé M García-Domínguez, Jorge Maurino, José E Meca-Lallana, et al.
Multiple Sclerosis and Related Disorders|August 31, 2024
Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?Gustavo Saposnik, Enric Monreal, Nicolas Medrano, et al.
Journal of Neuroinflammation|April 12, 2024
Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosisMaria T Cencioni, Roberta Magliozzi, Ilaria Palmisano, et al.
Vaccines|April 28, 2023
Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying TherapiesSusana Sainz de la Maza, Paulette Esperanza Walo-Delgado, Mario Rodríguez-Domínguez, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 21, 2020
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort studyEnric Monreal, Susana Sainz de la Maza, Elena Natera-Villalba, et al.
International Journal of Molecular Sciences|July 27, 2024
Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy AdultsAlexander Rodero-Romero, Enric Monreal, Raquel Sainz-Amo, et al.
CNS Drugs|February 28, 2024
Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM StudyLucienne Costa-Frossard França, Virginia Meca Lallana, Andrés Labiano-Fontcuberta, et al.
Journal of Neuroimmunology|August 9, 2024
Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?Jordi Tortosa-Carreres, Laura Cubas-Núñez, Mónica Piqueras, et al.
Frontiers in Immunology|October 25, 2021
Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With AlemtuzumabPaulette Esperanza Walo-Delgado, Enric Monreal, Silvia Medina, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Parkinsonism & Related Disorders|October 18, 2019
Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive studyAraceli Alonso-Canovas, José Ignacio Tembl Ferrairó, Irene Martínez-Torres, et al.
Journal of Personalized Medicine|February 25, 2025
Attitudes of Neurologists Toward Serum Neurofilament Light-Chain Testing in the Management of Relapsing-Remitting Multiple Sclerosis with Cognitive ImpairmentJosé M García-Domínguez, Jorge Maurino, José E Meca-Lallana, et al.
Multiple Sclerosis and Related Disorders|August 31, 2024
Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?Gustavo Saposnik, Enric Monreal, Nicolas Medrano, et al.
Journal of Neuroinflammation|April 12, 2024
Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosisMaria T Cencioni, Roberta Magliozzi, Ilaria Palmisano, et al.
Vaccines|April 28, 2023
Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying TherapiesSusana Sainz de la Maza, Paulette Esperanza Walo-Delgado, Mario Rodríguez-Domínguez, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 21, 2020
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort studyEnric Monreal, Susana Sainz de la Maza, Elena Natera-Villalba, et al.
International Journal of Molecular Sciences|July 27, 2024
Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy AdultsAlexander Rodero-Romero, Enric Monreal, Raquel Sainz-Amo, et al.
CNS Drugs|February 28, 2024
Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM StudyLucienne Costa-Frossard França, Virginia Meca Lallana, Andrés Labiano-Fontcuberta, et al.
Journal of Neuroimmunology|August 9, 2024
Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?Jordi Tortosa-Carreres, Laura Cubas-Núñez, Mónica Piqueras, et al.
Frontiers in Immunology|October 25, 2021
Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With AlemtuzumabPaulette Esperanza Walo-Delgado, Enric Monreal, Silvia Medina, et al.
Pageof 6